{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:16:16Z","timestamp":1772248576451,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimie"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.biochi.2024.10.014","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T19:48:06Z","timestamp":1729280886000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Engineered IgG Fc-conjugation prolongs the half-life of florfenicol and alleviates pneumonia in mice"],"prefix":"10.1016","volume":"229","author":[{"given":"Shikun","family":"Ge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto Carlos","family":"Pires Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biochi.2024.10.014_bib1","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1021\/jacs.7b13361","article-title":"Chemically defined antibody- and small molecule-drug conjugates for in\u00a0vivo tumor targeting applications: a comparative analysis","volume":"140","author":"Cazzamalli","year":"2018","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.biochi.2024.10.014_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121820","article-title":"In\u00a0vivo therapeutic effects of small molecule-drug conjugates enhanced by Fc grafting","volume":"290","author":"Zheng","year":"2022","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biochi.2024.10.014_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4161\/mabs.3.5.17334","article-title":"Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies","volume":"3","author":"Beck","year":"2011","journal-title":"mAbs"},{"key":"10.1016\/j.biochi.2024.10.014_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2018.06.016","article-title":"Influence of the dissociation rate constant on the intra-tumor distribution of antibody-drug conjugate against tissue factor","volume":"284","author":"Tsumura","year":"2018","journal-title":"J\u00a0Control Release"},{"issue":"7","key":"10.1016\/j.biochi.2024.10.014_bib5","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1021\/acs.jmedchem.1c00003","article-title":"Enhancing the pharmacokinetics and antitumor activity of an \u03b1-amanitin-based small-molecule drug conjugate via conjugation with an Fc domain","volume":"64","author":"Gallo","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"issue":"9","key":"10.1016\/j.biochi.2024.10.014_bib6","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1021\/acs.bioconjchem.9b00235","article-title":"Facile and efficient chemoenzymatic semisynthesis of fc-fusion compounds for half-life extension of pharmaceutical components","volume":"30","author":"Hirasawa","year":"2019","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.biochi.2024.10.014_bib7","first-page":"682","article-title":"Unraveling the interaction between FcRn and albumin: opportunities for design of albumin-based therapeutics","volume":"5","author":"Sand","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biochi.2024.10.014_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fimmu.2016.00214","article-title":"Immunoglobulin transporting receptors are potential targets for the immunity enhancement and generation of mammary gland bioreactor","volume":"7","author":"Jiang","year":"2016","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.biochi.2024.10.014_bib9","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1080\/19420862.2019.1633883","article-title":"Antibody Fc engineering for enhanced neonatal Fc receptor binding and prolonged circulation half-life","volume":"11","author":"Mackness","year":"2019","journal-title":"mAbs"},{"issue":"1","key":"10.1016\/j.biochi.2024.10.014_bib10","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/s41467-024-46321-9","article-title":"Human IgG Fc-engineering for enhanced plasma half-life, mucosal distribution and killing of cancer cells and bacteria","volume":"15","author":"Foss","year":"2024","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biochi.2024.10.014_bib11","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/emmm.201201379","article-title":"Fc-fusion proteins: new developments and future perspectives","volume":"4","author":"Czajkowsky","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.biochi.2024.10.014_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fimmu.2014.00146","article-title":"Interactions of IgG1 CH2 and CH3 domains with FcRn","volume":"5","author":"Ying","year":"2014","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.biochi.2024.10.014_bib13","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/AAC.01285-13","article-title":"A\u00a0novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults","volume":"57","author":"Robbie","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.biochi.2024.10.014_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/19420862.2015.1113360","article-title":"Pharmacokinetic properties of IgG and various Fc fusion proteins in mice","volume":"8","author":"Unverdorben","year":"2016","journal-title":"mAbs"},{"issue":"3","key":"10.1016\/j.biochi.2024.10.014_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.ARBA-0023-2017","article-title":"Antimicrobial stewardship in veterinary medicine","volume":"6","author":"Lloyd","year":"2018","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.biochi.2024.10.014_bib16","series-title":"Mader's Reptile and Amphibian Medicine and Surgery","first-page":"1139","article-title":"116 - antibiotic therapy","author":"Perry","year":"2019"},{"issue":"10","key":"10.1016\/j.biochi.2024.10.014_bib17","article-title":"Old antibiotics can learn new ways: a systematic review of florfenicol use in veterinary medicine and future perspectives using nanotechnology","volume":"13","author":"Trif","year":"2023","journal-title":"Animals (Basel)"},{"key":"10.1016\/j.biochi.2024.10.014_bib18","series-title":"Saunders Handbook of Veterinary Drugs","first-page":"327","article-title":"Florfenicol","author":"Papich","year":"2016"},{"issue":"1","key":"10.1016\/j.biochi.2024.10.014_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53304-0","article-title":"Comparative muscle irritation and pharmacokinetics of florfenicol-hydroxypropyl-\u03b2-cyclodextrin inclusion complex freeze-dried powder injection and florfenicol commercial injection in beagle dogs","volume":"9","author":"Fan","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biochi.2024.10.014_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/jvp.12714","article-title":"Pharmacokinetics of florfenicol and thiamphenicol in ducks","volume":"42","author":"Tikhomirov","year":"2019","journal-title":"J\u00a0Vet Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.biochi.2024.10.014_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/00071668.2016.1261994","article-title":"The influence of rapid growth in broilers on florfenicol pharmacokinetics - allometric modelling of the pharmacokinetic and haemodynamic parameters","volume":"58","author":"Po\u017aniak","year":"2017","journal-title":"Br Poult Sci"},{"issue":"1","key":"10.1016\/j.biochi.2024.10.014_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.rvsc.2008.10.010","article-title":"Pharmacokinetics of florfenicol after intravenous and intramuscular administration in New Zealand White rabbits","volume":"87","author":"Koc","year":"2009","journal-title":"Res. Vet. Sci."},{"issue":"3","key":"10.1016\/j.biochi.2024.10.014_bib23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jmb.2009.06.048","article-title":"Structure of the murine unglycosylated IgG1 Fc fragment","volume":"391","author":"Feige","year":"2009","journal-title":"J.\u00a0Mol. Biol."},{"issue":"10","key":"10.1016\/j.biochi.2024.10.014_bib24","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/s41596-022-00728-0","article-title":"I-TASSER-MTD: a deep-learning-based platform for multi-domain protein structure and function prediction","volume":"17","author":"Zhou","year":"2022","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biochi.2024.10.014_bib25","first-page":"255","article-title":"Small-molecule-protein conjugation procedures","volume":"94","author":"Thompson","year":"2004","journal-title":"Methods Mol. Med."},{"issue":"12","key":"10.1016\/j.biochi.2024.10.014_bib26","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1021\/acs.bioconjchem.5b00530","article-title":"Fc-small molecule antibody mimetics","volume":"26","author":"Wold","year":"2015","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.biochi.2024.10.014_bib27","first-page":"47","article-title":"Methods of blood collection in the mouse","volume":"29","author":"Wolforth","year":"2000","journal-title":"Lab. Anim."},{"issue":"2","key":"10.1016\/j.biochi.2024.10.014_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0976-500X.72350","article-title":"Blood sample collection in small laboratory animals","volume":"1","author":"Parasuraman","year":"2010","journal-title":"J.\u00a0Pharmacol. Pharmacother."},{"issue":"4","key":"10.1016\/j.biochi.2024.10.014_bib29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/0023677213494366","article-title":"Validation of a refined technique for taking repeated blood samples from juvenile and adult mice","volume":"47","author":"Sadler","year":"2013","journal-title":"Lab Anim"},{"issue":"1","key":"10.1016\/j.biochi.2024.10.014_bib30","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1021\/acs.analchem.9b04419","article-title":"Stable isotope dilution LC-HRMS assay to determine free SN-38, total SN-38, and SN-38G in a tumor xenograft model after intravenous administration of antibody-drug conjugate (sacituzumab govitecan)","volume":"92","author":"Pandey","year":"2020","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.biochi.2024.10.014_bib31","first-page":"226","article-title":"[A mouse model of acute lung inflammation induced by lipopolysaccharide inhalation]","volume":"41","author":"Guo","year":"2009","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.biochi.2024.10.014_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106990","article-title":"Ganoderic acid B attenuates LPS-induced lung injury","volume":"88","author":"Shi","year":"2020","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"10.1016\/j.biochi.2024.10.014_bib33","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1213\/01.ANE.0000086896.90343.13","article-title":"ONO-1714, a nitric oxide synthase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits","volume":"97","author":"Mikawa","year":"2003","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.biochi.2024.10.014_bib34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.biochi.2024.10.014_bib35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/biomedicines5040064","article-title":"Site-specific antibody conjugation for ADC and beyond","volume":"5","author":"Zhou","year":"2017","journal-title":"Biomedicines"},{"issue":"17","key":"10.1016\/j.biochi.2024.10.014_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179604","article-title":"Monoclonal antibody engineering and design to modulate FcRn activities: a comprehensive review","volume":"23","author":"Ramdani","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.biochi.2024.10.014_bib37","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.addr.2006.09.009","article-title":"Multifunctional nanocarriers","volume":"58","author":"Torchilin","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"21","key":"10.1016\/j.biochi.2024.10.014_bib38","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.biochi.2024.10.014_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2008.05.010","article-title":"Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles","volume":"132","author":"Kratz","year":"2008","journal-title":"J\u00a0Control Release"},{"issue":"6478","key":"10.1016\/j.biochi.2024.10.014_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.biochi.2024.10.014_bib41","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1021\/ja5006674","article-title":"An Fc domain protein-small molecule conjugate as an enhanced immunomodulator","volume":"136","author":"Chiang","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.biochi.2024.10.014_bib42","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41598-018-19170-y","article-title":"Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice","volume":"8","author":"Shi","year":"2018","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.biochi.2024.10.014_bib43","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/cbic.201600337","article-title":"An fc-small molecule conjugate for targeted inhibition of the adenosine 2A receptor","volume":"17","author":"Hsiao","year":"2016","journal-title":"Chembiochem"},{"issue":"1","key":"10.1016\/j.biochi.2024.10.014_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0022-1759(86)90497-7","article-title":"Hapten-protein conjugates prepared by the mixed anhydride method. Cross-reactive antibodies in heterologous antisera","volume":"92","author":"Gendloff","year":"1986","journal-title":"J.\u00a0Immunol. Methods"},{"issue":"4","key":"10.1016\/j.biochi.2024.10.014_bib45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2885.1986.tb00062.x","article-title":"Pharmacokinetics of florfenicol in veal calves","volume":"9","author":"Varma","year":"1986","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.biochi.2024.10.014_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fmicb.2016.00389","article-title":"Florfenicol as a modulator enhancing antimicrobial activity: example using combination with thiamphenicol against pasteurella multocida","volume":"7","author":"Wei","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.biochi.2024.10.014_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.687926","article-title":"Linker design impacts antibody-drug conjugate pharmacokinetics and efficacy via modulating the stability and payload release efficiency","volume":"12","author":"Su","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.biochi.2024.10.014_bib48","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4161\/mabs.19449","article-title":"Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates","volume":"4","author":"Acchione","year":"2012","journal-title":"mAbs"},{"issue":"1","key":"10.1016\/j.biochi.2024.10.014_bib49","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12929-020-00673-8","article-title":"Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes","volume":"27","author":"Szpirer","year":"2020","journal-title":"J.\u00a0Biomed. Sci."},{"issue":"10","key":"10.1016\/j.biochi.2024.10.014_bib50","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1007\/s00262-021-02897-5","article-title":"Modeling human tumor-immune environments in\u00a0vivo for the preclinical assessment of immunotherapies","volume":"70","author":"Bareham","year":"2021","journal-title":"Cancer Immunol. Immunother."}],"container-title":["Biochimie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908424002402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300908424002402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:13:45Z","timestamp":1737591225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300908424002402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":50,"alternative-id":["S0300908424002402"],"URL":"https:\/\/doi.org\/10.1016\/j.biochi.2024.10.014","relation":{},"ISSN":["0300-9084"],"issn-type":[{"value":"0300-9084","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered IgG Fc-conjugation prolongs the half-life of florfenicol and alleviates pneumonia in mice","name":"articletitle","label":"Article Title"},{"value":"Biochimie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biochi.2024.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. and Soci\u00e9t\u00e9 Fran\u00e7aise de Biochimie et Biologie Mol\u00e9culaire (SFBBM). All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}